These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 34668734)

  • 1. Intestinal Bacteriophage Therapy: Looking for Optimal Efficacy.
    Javaudin F; Latour C; Debarbieux L; Lamy-Besnier Q
    Clin Microbiol Rev; 2021 Dec; 34(4):e0013621. PubMed ID: 34668734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacteriophage: A Useful Tool for Studying Gut Bacteria Function of Housefly Larvae, Musca domestica.
    Zhang X; Wang S; Li T; Zhang Q; Zhang R; Zhang Z
    Microbiol Spectr; 2021 Sep; 9(1):e0059921. PubMed ID: 34378967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacteriophage-based techniques for elucidating the function of zebrafish gut microbiota.
    Jia PP; Yang YF; Junaid M; Jia HJ; Li WG; Pei DS
    Appl Microbiol Biotechnol; 2023 Apr; 107(7-8):2039-2059. PubMed ID: 36847856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A bacteriophage cocktail targeting Escherichia coli reduces E. coli in simulated gut conditions, while preserving a non-targeted representative commensal normal microbiota.
    Cieplak T; Soffer N; Sulakvelidze A; Nielsen DS
    Gut Microbes; 2018; 9(5):391-399. PubMed ID: 29517960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the animal host in the management of bacteriophage resistance during phage therapy.
    Gaborieau B; Debarbieux L
    Curr Opin Virol; 2023 Feb; 58():101290. PubMed ID: 36512896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting antibiotic resistant bacteria with phage reduces bacterial density in an insect host.
    Mikonranta L; Buckling A; Jalasvuori M; Raymond B
    Biol Lett; 2019 Mar; 15(3):20180895. PubMed ID: 30836884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacteriophages to reduce gut carriage of antibiotic resistant uropathogens with low impact on microbiota composition.
    Galtier M; De Sordi L; Maura D; Arachchi H; Volant S; Dillies MA; Debarbieux L
    Environ Microbiol; 2016 Jul; 18(7):2237-45. PubMed ID: 26971586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacteriophages as Therapeutic Agents: Alternatives to Antibiotics.
    Samir S
    Recent Pat Biotechnol; 2021; 15(1):25-33. PubMed ID: 33475081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shining Light on Human Gut Bacteriophages.
    Guerin E; Hill C
    Front Cell Infect Microbiol; 2020; 10():481. PubMed ID: 33014897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Expansion of a Single Bacteriophage Leads to Bacterial Disturbance in Gut and Reduction of Larval Growth in
    Zhang X; Wang S; Zhang Q; Zhang K; Liu W; Zhang R; Zhang Z
    Front Immunol; 2022; 13():885722. PubMed ID: 35464464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "I will survive": A tale of bacteriophage-bacteria coevolution in the gut.
    De Sordi L; Lourenço M; Debarbieux L
    Gut Microbes; 2019; 10(1):92-99. PubMed ID: 29913091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decolonization of asymptomatic carriage of multi-drug resistant bacteria by bacteriophages?
    Bonnet M; Eckert C; Tournebize R
    Front Microbiol; 2023; 14():1266416. PubMed ID: 38075897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacteriophages, gut bacteria, and microbial pathways interplay in cardiometabolic health.
    Kirk D; Costeira R; Visconti A; Khan Mirzaei M; Deng L; Valdes AM; Menni C
    Cell Rep; 2024 Feb; 43(2):113728. PubMed ID: 38300802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naturally-occurring and cultured bacteriophages in human therapy.
    Kiani AK; Anpilogov K; Dhuli K; Paolacci S; Benedetti S; Manara E; Guerri G; Dautaj A; Beccari T; Dundar M; Bertelli M
    Eur Rev Med Pharmacol Sci; 2021 Dec; 25(1 Suppl):101-107. PubMed ID: 34890040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacteriophages for ESKAPE: role in pathogenicity and measures of control.
    Patil A; Banerji R; Kanojiya P; Koratkar S; Saroj S
    Expert Rev Anti Infect Ther; 2021 Jul; 19(7):845-865. PubMed ID: 33261536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Gut Microbiota Facilitates Drifts in the Genetic Diversity and Infectivity of Bacterial Viruses.
    De Sordi L; Khanna V; Debarbieux L
    Cell Host Microbe; 2017 Dec; 22(6):801-808.e3. PubMed ID: 29174401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances and optimization strategies in bacteriophage therapy for treating inflammatory bowel disease.
    Li Y; Li XM; Duan HY; Yang KD; Ye JF
    Front Immunol; 2024; 15():1398652. PubMed ID: 38779682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic Modulation of the Gut Microbiota and Metabolome by Bacteriophages in a Mouse Model.
    Hsu BB; Gibson TE; Yeliseyev V; Liu Q; Lyon L; Bry L; Silver PA; Gerber GK
    Cell Host Microbe; 2019 Jun; 25(6):803-814.e5. PubMed ID: 31175044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examining the Effects of an Anti-Salmonella Bacteriophage Preparation, BAFASAL
    Mayne J; Zhang X; Butcher J; Walker K; Ning Z; Wójcik E; Dastych J; Stintzi A; Figeys D
    Viruses; 2021 Aug; 13(9):. PubMed ID: 34578313
    [No Abstract]   [Full Text] [Related]  

  • 20. Review article: bacteriophages in gastroenterology-from biology to clinical applications.
    Sabino J; Hirten RP; Colombel JF
    Aliment Pharmacol Ther; 2020 Jan; 51(1):53-63. PubMed ID: 31696976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.